Prothena to Participate in Upcoming Healthcare Conferences
DUBLIN, August 29, 2024--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dy...